Felipe Ridolfi, MD, MSc, recently completed his Ph.D. sandwich program at VUMC, where he was hosted by the TB Center. Here a few highlights of his time with us.
VUMC investigators and staff, Timothy Sterling, Yuri van der Heijden, Stephany Duda, Marina Figueiredo, Fernanda Mauri, Megan Turner, Maria Arriaga, and Austin Katona; attended the annual RePORT International meeting that was held in Goa, India September 6, 7 and 8, 2023.
The Regional Prospective Observational Research in Tuberculosis - Brazil (RePORT-Brazil) network is pleased to announce its 1st Cohort of Fellows for the RePORT-Brazil Advanced Career Training (ReACT) program.
Strategic Aim 3 of the recently renewed RePORT-Brazil Phase 2 grant (NIH U01AI172064-01), focuses on the development of a fellowship program for the advancement of early-career Brazilian scientists. The program provides funding for pilot projects in TB research, mentorship, and access to data and specimens collected throughout Phase 1 of the project.
Prof. Gavin Churchyard, CEO; Mr. Arshad Hassim, CFO; and Dr. Violet Chihota, Chief Specialist Scientist of the Aurum Institute, visited VUMC from August 21st to August 25th. Their visit strengthens the ongoing collaborative partnership between the two institutions, which is focused on research and global health. Included in the visit were a variety of strategic planning meetings, programmatic evaluations, and a presentation at ID Grand Rounds by Dr. Violet Chihota.
Dr. María Belen Arriaga Gutiérrez, post-doctoral scholar at the Vanderbilt Tuberculosis Center, recently received commendations for her doctoral thesis "Clinical and Epidemiologic Determinants of Susceptibility to Infection by Mycobacterium tuberculosis and the Therapeutic Responses in Patients with Tuberculosis” from the Brazilian Department of Education and CAPES, Coordination for the Improvement of Higher Education.
Open Date (Earliest Submission Date): October 05, 2023
Expiration Date: July 17, 2026
This Notice of Special Interest (NOSI) encourages applications that seek to better understand Pulmonary Non-Tuberculous Mycobacteria (NTM) Infections and inform development of medical countermeasures. This NOSI aims to stimulate advances in diagnosis and treatment of NTM infections that cause or exacerbate pulmonary disease such as Mycobacterium abscessus, Mycobacterium avium complex, and Mycobacterium kansasii.